Gabriella Szekely, Ph.D.

Gabriella Szekely, Ph.D., Vice President, Research & Development, Combination Pharmaceutical Products

Dr. Szekely has served as our vice president, research and development, combination pharmaceutical products since September 2018. She previously served as our vice president, translational sciences since joining Glaukos in 2015. Dr. Szekely has over 20 years of experience in pharmaceutical drug development and life sciences industry product development. Between 2008 and 2015, she held positions of increasing responsibilities at Allergan, most recent being vice president of translational sciences within the nonclinical safety sciences organization that included oversight of the nonclinical pharmacokinetics and drug disposition, clinical pharmacology, formulation laboratories, and scientific operations. Prior to that, she held several leadership positions at Assay Designs/Enzo Life Sciences from 2007 to 2008, Pfizer’s research and development laboratories from 2001 to 2007, and 3M from 1997 to 2001. Dr. Szekely completed her doctorate in physical chemistry at the Kossuth University in Hungary and Ph.D. in chemistry at Michigan State University.